174 related articles for article (PubMed ID: 2761266)
1. Quantification of estrogen- and progesterone receptors from cryostat sectioned human tumor tissue: comparison of ligand binding and immunocytochemical assays.
Vollmer G; Gerdes J; Knuppen R
J Steroid Biochem; 1989 Jul; 33(1):41-7. PubMed ID: 2761266
[TBL] [Abstract][Full Text] [Related]
2. An improved micromethod for the determination of biochemically active estrogen and progesterone receptors in parallel to comparative histological examination of a single piece of tissue.
Vollmer G; Bindewald I; Meyn U; Wünsche WO; Arnholdt H; Knuppen R
J Steroid Biochem; 1988 Dec; 31(6):899-907. PubMed ID: 3199826
[TBL] [Abstract][Full Text] [Related]
3. Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity.
Goussard J
Cancer Lett; 1998 Oct; 132(1-2):61-6. PubMed ID: 10397454
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor quantification with radiolabeled promegestone (R 5020) in frozen sections of endometrium and breast cancer tissue.
De Goeij AF; Scheres HM; Rousch MJ; Hondius GG; Bosman FT
J Steroid Biochem; 1988 May; 29(5):465-74. PubMed ID: 3379955
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of oestrogen and progesterone receptors by a ligand binding assay in frozen sections.
Vollmer G; Helmchen B; Knuppen R
J Clin Chem Clin Biochem; 1989 Dec; 27(12):953-9. PubMed ID: 2614342
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques.
Cappelletti V; Patriarca C; Granata G; Cattoretti G; Coradini D; Di Fronzo G; Horwitz K
Breast Cancer Res Treat; 1989 Nov; 14(2):217-25. PubMed ID: 2690973
[TBL] [Abstract][Full Text] [Related]
7. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
8. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
9. Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
Helin HJ; Isola JJ; Helle MJ; Adlercreutz H
Breast Cancer Res Treat; 1988 Sep; 12(1):67-73. PubMed ID: 3196886
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters.
Helle M; Helin M; Isola J; Helin H
J Cancer Res Clin Oncol; 1989; 115(4):361-5. PubMed ID: 2760100
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of estrogen and progesterone receptors in tumor cytosols with use of 125I-labeled estradiol and of 3H-R5020.
Thibodeau SN; Freeman L; Jiang NS
Clin Chem; 1981 May; 27(5):687-91. PubMed ID: 7194749
[TBL] [Abstract][Full Text] [Related]
13. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
Press MF; Xu SH; Wang JD; Greene GL
Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas.
DeRosa CM; Ozzello L; Habif DV; Konrath JG; Greene GL
Ann Surg; 1989 Aug; 210(2):224-8. PubMed ID: 2547346
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.
King WJ; DeSombre ER; Jensen EV; Greene GL
Cancer Res; 1985 Jan; 45(1):293-304. PubMed ID: 3965140
[TBL] [Abstract][Full Text] [Related]
17. Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas.
Vollmer G; Gerdes J; Knuppen R
Cancer Res; 1989 Jul; 49(14):4011-4. PubMed ID: 2736540
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
[TBL] [Abstract][Full Text] [Related]
19. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
20. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.
Norgren A; Borg A; Fernö M; Johansson U; Lindahl B; Tsiobanelis K
Anticancer Res; 1982; 2(5):315-20. PubMed ID: 6187272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
